A review of 35 studies found women with endometriosis had 2.3 times the odds of migraine, while short-term records missed much of the overlap.
The overlap is larger than routine records suggest
Endometriosis and migraine are often handled by separate specialists, and that division may obscure how frequently the conditions occur together. An analysis of more than 13 million women found that those with endometriosis had 2.3 times the odds of migraine compared with women without it. That’s a substantial association, but it doesn’t show that endometriosis causes migraine—or explain why the two appear together so often.
The distinction matters because both conditions can involve pain that is difficult to characterize and may be reported across different parts of the health system. If one clinician sees pelvic symptoms and another sees headaches, neither may have a clear view of the patient’s full pattern. The study raises a practical question: how much of the overlap is being missed because the conditions are assessed separately?
How much the estimates depend on the data
Presented at the American Neurological Association’s annual meeting, the analysis combined 35 studies spanning 50 years. It compared migraine rates among 207,675 women with endometriosis and nearly 13 million women without the condition. That scale gives the researchers a broad basis for comparison, though the combined studies didn’t all look for migraine in the same way.
The method used to identify migraine made a striking difference. Studies based on a single year of insurance billing records found migraine in fewer than 5% of women with endometriosis. Longer insurance claims produced estimates ranging from about 18% to 43%. In clinic studies, where women were asked directly about their symptoms, reported rates climbed to 54%–78%.
Those estimates shouldn’t be treated as interchangeable. A billing record captures what was coded during a particular period; a direct question can surface symptoms that never led to a recorded diagnosis. Clinic studies also involve people seeking care, so their results may not describe every woman with endometriosis. The numbers here are underwhelming as a measure of certainty, but striking as evidence that the way researchers ask the question can shape the answer.
That gap suggests routine records can miss a substantial share of people living with both conditions. The researchers estimate that short-term medical records may fail to capture up to 90% of cases. When care is split between gynecology and neurology, symptoms recorded in one setting may never prompt questions in the other. (And this is the part most people overlook: a condition can be common among patients and still remain invisible in the records used to count it.)
A possible biological link
The overlap may reflect more than shared patients. Researchers are investigating calcitonin gene-related peptide, or CGRP, a chemical messenger involved in pain signaling and inflammation in nerve tissue. Its role in migraine is well established; whether it also contributes to endometriosis pain remains uncertain.
Endometriosis involves inflammation, scarring, and nerve activity, making CGRP a plausible subject for further study. Similar questions arise in other conditions where pain and inflammation intersect: a shared pathway can suggest a research direction without proving that the same mechanism drives every patient’s symptoms. Here’s the thing: biological plausibility is a starting point, not a treatment result.
Some CGRP-targeting medicines are already used to prevent migraine attacks. The findings support research into whether these drugs might also ease endometriosis pain, though the analysis does not establish that they do. That’s an open question, not a clinical conclusion.
What the findings mean for care and research
For patients with severe pelvic pain and migraine, the findings make a practical case for describing both sets of symptoms to each clinician. A neurologist may not ask about menstrual pain, and a gynecologist may not ask about headaches; sharing that history could help connect symptoms that otherwise remain in separate records. If you’re working in this space, the study points to a basic improvement in assessment: ask about the other condition instead of assuming another specialist has already covered it.
A simple log of migraine episodes and pelvic pain in relation to the menstrual cycle can give a care team useful context. It won’t establish a diagnosis or show that one symptom causes the other, but it can make timing and recurrence easier to discuss. A clearer history, with symptoms considered together.
The central finding is that the apparent frequency of this overlap changes sharply with how clinicians look for it. Better symptom histories may help identify it sooner, while research tests whether the suspected shared pathway can inform treatment. That said, the next step is evidence: whether CGRP has a meaningful role in endometriosis pain, and whether targeting it changes outcomes for patients who have both conditions.
Discussion
Sign in to join the discussion.